Primary Biliary Cirrhosis Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
Phase 2 Study to Evaluate LUM001 in Combination With Ursodeoxycholic Acid in Patients With Primary Biliary Cirrhosis
Conditions: Primary Biliary Cirrhosis; PBCInterventions: Drug: LUM001; Drug: Placebo; Drug: Ursodeoxycholic AcidSponsor: Lumena Pharmaceuticals, Inc.Active, not recruiting - verified December 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 17, 2013 Category: Research Source Type: clinical trials
Phase 2 Study to Evaluate LUM001 in Combination With Ursodeoxycholic Acid in Patients With Primary Biliary Cirrhosis
Conditions: Primary Biliary Cirrhosis; PBCInterventions: Drug: LUM001; Drug: Placebo; Drug: Ursodeoxycholic AcidSponsor: ShireCompleted - verified April 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 17, 2013 Category: Research Source Type: clinical trials
Phase 2 Study to Evaluate LUM001 in Combination With Ursodeoxycholic Acid in Patients With Primary Biliary Cirrhosis
Conditions: Primary Biliary Cirrhosis; PBCInterventions: Drug: LUM001; Drug: Placebo; Drug: Ursodeoxycholic AcidSponsor: Lumena Pharmaceuticals, Inc.Active, not recruiting - verified December 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 17, 2013 Category: Research Source Type: clinical trials
Phase 2 Study to Evaluate LUM001 in Combination With Ursodeoxycholic Acid in Patients With Primary Biliary Cirrhosis
Conditions: Primary Biliary Cirrhosis; PBCInterventions: Drug: LUM001; Drug: Placebo; Drug: Ursodeoxycholic AcidSponsor: Lumena Pharmaceuticals, Inc.Active, not recruiting - verified March 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 17, 2013 Category: Research Source Type: clinical trials
Phase 2 Study to Evaluate LUM001 in Combination With Ursodeoxycholic Acid in Patients With Primary Biliary Cirrhosis
Conditions: Primary Biliary Cirrhosis; PBCInterventions: Drug: LUM001; Drug: Placebo; Drug: Ursodeoxycholic AcidSponsor: Lumena Pharmaceuticals, Inc.Completed - verified April 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 17, 2013 Category: Research Source Type: clinical trials
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Repeat Doses of GSK2330672 Administration in Subjects With Primary Biliary Cirrhosis (PBC) and Symptoms of Pruritus
Condition: Cholestasis, IntrahepaticInterventions: Drug: GSK2330672; Drug: Placebo; Drug: Ursodeoxycholic acidSponsor: GlaxoSmithKlineRecruiting - verified March 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 3, 2013 Category: Research Source Type: clinical trials